Judges ScientificPLC - Director/PDMR Shareholding

Judges Scientific

29/01/2026 15:31

RNS Number : 9767Q

Judges Scientific PLC

29 January 2026

 

29 January 2026

 

Judges Scientific plc

("Judges Scientific" or the "Company")

 

Exercise of Options

 

Judges Scientific announces that David Cicurel, Chief Executive Officer, on 29 January 2026 exercised options over 7,500 new ordinary shares of 5 pence each in the Company ("Ordinary Shares").

 

Following this exercise David Cicurel is beneficially interested in 551,892 Ordinary Shares and beneficially and non beneficially interested in 618,892 Ordinary Shares, his non beneficial interest comprising 67,000 Ordinary Shares he has gifted to Shoftim Charitable Trust.

 

Following the above exercise of options, the Company's total issued share capital has increased to 6,660,444 Ordinary Shares. There are no Ordinary Shares held in treasury. Each Ordinary Share carries voting rights on the basis of one vote per Ordinary Share. Therefore, the total number of voting rights in Judges Scientific is 6,660,444 Ordinary Shares. The above figure may be used by shareholders as the denominator for calculations to determine if they have a notifiable interest in Judges Scientific under the Disclosure and Transparency Rules, or if such interest has changed.

 

For further information please contact: 

 

Judges Scientific plc
David Cicurel, CEO
Brad Ormsby, CFO
Tel: +44 (0) 20 3829 6970
Shore Capital (Nominated Adviser & Joint Broker)
Stephane Auton
Harry Davies-Ball
Tel: +44 (0) 20 7408 4090
Panmure Liberum (Joint Broker)
Edward Mansfield
William King
Tel : +44 (0) 20 3100 2222
Investec Bank plc (Joint Broker)
Virginia Bull
Carlton Nelson
Tel: +44 (0) 20 7597 4000
Alma (Financial Public Relations)
Sam Modlin
Rebecca Sanders-Hewett
Joe Pederzolli
Sarah Peters
Tel: +44 (0) 20 3405 0205
judges@almastrategic.com


 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector.  The Group consists of 25 businesses acquired since 2005.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including higher education institutions, scientific research facilities, manufacturers, and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments.  The Group has received five Queen's Awards for Innovation and Export.

 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.  Shareholder returns are created through the reduction of debt, organic growth, and dividends.

 

For further information, please visit www.judges.uk.com

 

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
David Cicurel
2
Reason for the notification
a)
Position/status
Chief Executive Officer
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Judges Scientific plc
b)
LEI
2138004EXWWPTW1JOL31
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares in Judges Scientific plc
GB0032398678
b)
Nature of the transaction
Exercise of Options
c)
Price(s) and volume(s)
Price(s)
Volume(s)
1,402.5p
7,500
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
29/01/2026
f)
Place of the transaction
London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBUGDBGXDDGLC